G12 signaling through c-jun nh 2-terminal kinase promotes breast cancer cell invasion

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Juneja, Juhi ^a   Cushman, Ian ^a,b   Casey, Patrick J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

G12 PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHO KINASE INHIBITOR; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; THROMBIN; UNCLASSIFIED DRUG; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEEDBACK SYSTEM; GENE SILENCING; MOLECULAR PATHOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BREAST TUMOR; FEMALE; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

BASEMENT MEMBRANE; BREAST NEOPLASMS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 80455174516     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026085     Document Type: Article

References (47)

1. Marinissen MJ, Gutkind JS, (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368-376.
2. Offermanns S, (2001) In vivo functions of heterotrimeric G-proteins: studies in Galpha-deficient mice. Oncogene 20: 1635-1642.
3. Kelly P, Casey PJ, Meigs TE, (2007) Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis. Biochemistry 46: 6677-6687.
4. Radhika V, Dhanasekaran N, (2001) Transforming G proteins. Oncogene 20: 1607-1614.
5. Chan AM, Fleming TP, McGovern ES, Chedid M, Miki T, et al. (1993) Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Mol Cell Biol 13: 762-768.
6. Juneja J, Casey PJ, (2009) Role of G12 proteins in oncogenesis and metastasis. Br J Pharmacol 158: 32-40.
7. Dorsam RT, Gutkind JS, (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94.
8. Worzfeld T, Wettschureck N, Offermanns S, (2008) G(12)/G(13)-mediated signalling in mammalian physiology and disease. Trends Pharmacol Sci 29: 582-589.
9. Kurose H, (2003) Galpha12 and Galpha13 as key regulatory mediator in signal transduction. Life Sci 74: 155-161.
10. Dermott JM, Ha JH, Lee CH, Dhanasekaran N, (2004) Differential regulation of Jun N-terminal kinase and p38MAP kinase by Galpha12. Oncogene 23: 226-232.
11. Voyno-Yasenetskaya TA, Faure MP, Ahn NG, Bourne HR, (1996) Galpha12 and Galpha13 regulate extracellular signal-regulated kinase and c-Jun kinase pathways by different mechanisms in COS-7 cells. J Biol Chem 271: 21081-21087.
12. Goldsmith ZG, Dhanasekaran DN, (2007) G protein regulation of MAPK networks. Oncogene 26: 3122-3142.
13. Arai K, Maruyama Y, Nishida M, Tanabe S, Takagahara S, et al. (2003) Differential requirement of G alpha12, G alpha13, G alphaq, and G beta gamma for endothelin-1-induced c-Jun NH2-terminal kinase and extracellular signal-regulated kinase activation. Mol Pharmacol 63: 478-488.
14. Lee YN, Malbon CC, Wang HY, (2004) G alpha 13 signals via p115RhoGEF cascades regulating JNK1 and primitive endoderm formation. J Biol Chem 279: 54896-54904.
15. Karin M, Liu Z, Zandi E, (1997) AP-1 function and regulation. Curr Opin Cell Biol 9: 240-246.
16. Jho EH, Davis RJ, Malbon CC, (1997) c-Jun amino-terminal kinase is regulated by Galpha12/Galpha13 and obligate for differentiation of P19 embryonal carcinoma cells by retinoic acid. J Biol Chem 272: 24468-24474.
17. Marinissen MJ, Servitja JM, Offermanns S, Simon MI, Gutkind JS, (2003) Thrombin protease-activated receptor-1 signals through Gq- and G13-initiated MAPK cascades regulating c-Jun expression to induce cell transformation. J Biol Chem 278: 46814-46825.
18. Radhika V, Hee Ha J, Jayaraman M, Tsim ST, Dhanasekaran N, (2005) Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12. Oncogene 24: 4597-4603.
19. Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, et al. (2006) The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 103: 8173-8178.
20. Kelly P, Stemmle LN, Madden JF, Fields TA, Daaka Y, et al. (2006) A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion. J Biol Chem 281: 26483-26490.
21. Li G, Xiang Y, Sabapathy K, Silverman RH, (2004) An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem 279: 1123-1131.
22. Meigs TE, Juneja J, DeMarco CT, Stemmle LN, Kaplan DD, et al. (2005) Selective uncoupling of G alpha 12 from Rho-mediated signaling. J Biol Chem 280: 18049-18055.
23. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, et al. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770.
24. Bain J, McLauchlan H, Elliott M, Cohen P, (2003) The specificities of protein kinase inhibitors: an update. Biochem J 371: 199-204.
25. Wang J, Kuiatse I, Lee AV, Pan J, Giuliano A, et al. (2010) Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation. Mol Cancer Res 8: 266-277.
26. Malchinkhuu E, Sato K, Horiuchi Y, Mogi C, Ohwada S, et al. (2005) Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells. Oncogene 24: 6676-6688.
27. Cheung LW, Leung PC, Wong AS, (2006) Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. Cancer Res 66: 10902-10910.
28. Shimada K, Nakamura M, Ishida E, Higuchi T, Tanaka M, et al. (2007) c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas. Am J Pathol 171: 1003-1012.
29. Riobo NA, Manning DR, (2005) Receptors coupled to heterotrimeric G proteins of the G12 family. Trends Pharmacol Sci 26: 146-154.
30. Amano M, Fukata Y, Kaibuchi K, (2000) Regulation and functions of Rho-associated kinase. Exp Cell Res 261: 44-51.
31. Geneste O, Copeland JW, Treisman R, (2002) LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics. J Cell Biol 157: 831-838.
32. Marinissen MJ, Chiariello M, Tanos T, Bernard O, Narumiya S, et al. (2004) The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 14: 29-41.
33. Zhang L, Deng M, Parthasarathy R, Wang L, Mongan M, et al. (2005) MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 25: 60-65.
34. Nishida M, Tanabe S, Maruyama Y, Mangmool S, Urayama K, et al. (2005) G alpha 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. J Biol Chem 280: 18434-18441.
35. Hall A, (1998) Rho GTPases and the actin cytoskeleton. Science 279: 509-514.
36. Buhl AM, Johnson NL, Dhanasekaran N, Johnson GL, (1995) G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J Biol Chem 270: 24631-24634.
37. Sotiropoulos A, Gineitis D, Copeland J, Treisman R, (1999) Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98: 159-169.
38. Fromm C, Coso OA, Montaner S, Xu N, Gutkind JS, (1997) The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation. Proc Natl Acad Sci U S A 94: 10098-10103.
39. Raftopoulou M, Hall A, (2004) Cell migration: Rho GTPases lead the way. Dev Biol 265: 23-32.
40. Sahai E, Marshall CJ, (2003) Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5: 711-719.
41. Sahai E, Olson MF, Marshall CJ, (2001) Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J 20: 755-766.
42. Tabu K, Ohba Y, Suzuki T, Makino Y, Kimura T, et al. (2007) Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA. Mol Cancer Res 5: 1099-1109.
43. Xu J, Wang F, Van Keymeulen A, Herzmark P, Straight A, et al. (2003) Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 114: 201-214.
44. Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN, (2005) JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry 44: 14090-14096.
45. Lee CM, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP, (2002) JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A 99: 14189-14194.
46. Kashef K, Radhakrishnan R, Lee CM, Reddy EP, Dhanasekaran DN, (2011) Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein. Neoplasia 13: 358-364.
47. Liu SC, Jen YM, Jiang SS, Chang JL, Hsiung CA, et al. (2009) G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization. Cancer Res 69: 6122-6130.